Fibrin‐specific poly(N‐isopropylacrylamide) nanogels for targeted delivery of tissue‐type plasminogen activator to treat thrombotic complications are well tolerated in vivo von Mihalko, Emily P., Nellenbach, Kimberly, Krishnakumar, Manasi, Moiseiwitsch, Nina, Sollinger, Jennifer, Cooley, Brian C., Brown, Ashley C.

Volltext

COVID‐19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid von Moiseiwitsch, Nina, Zwennes, Nicole, Szlam, Fania, Sniecinski, Roman, Brown, Ashley

Volltext

Neonatal coagulopathies: A review of established and emerging treatments von Moiseiwitsch, Nina, Brown, Ashley C

Volltext

Ex Vivo and In Vivo Evaluation of Fibrinogen Concentrate to Mitigate Post-Surgical Bleeding in Neonates von Moiseiwitsch, Nina, Nellenbach, Kimberly A, Guzzetta, Nina A, Brown, Ashley C, Downey, Laura

Volltext

Influence of Fibrinogen Concentrate on Neonatal Clot Structure When Administered Ex Vivo After Cardiopulmonary Bypass von Moiseiwitsch, Nina, Nellenbach, Kimberly A., Downey, Laura A., Boorman, David, Brown, Ashley C., Guzzetta, Nina A.

Volltext

Clot-Targeted Nanogels for Dual-Delivery of AntithrombinIII and Tissue Plasminogen Activator to Mitigate Disseminated Intravascular Coagulation Complications von Sheridan, Anastasia, Nellenbach, Kimberly, Pandit, Sanika, Byrnes, Elizabeth, Hardy, Grace, Lutz, Halle, Moiseiwitsch, Nina, Scull, Grant, Mihalko, Emily, Levy, Jerrold H., Brown, Ashley C.

Volltext